⌘K

Home/Filings/4/0001209191-15-056900

4//SEC Filing

Regulus Therapeutics Inc. 4

Accession 0001209191-15-056900

CIK 0001505512operating

View on SEC.gov Company Profile

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 5:47 PM ET

Size

5.5 KB

Accession

0001209191-15-056900

Insider Transaction Report

Form 4

Period: 2015-06-25

Regulus Therapeutics Inc.RGLS

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2015-06-25+500,000→ 500,000 total
Exercise: $10.22Exp: 2025-06-24→ Common Stock (500,000 underlying)

Footnotes (1)

[F1]Twenty-Five percent of the options will vest on the one year anniversary date of the grant and the balance of the shares will vest in a series of thirty-six equal monthly installments thereafter, such that the option is fully vested on the fourth anniversary of the date of grant.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Regulus Therapeutics Inc.

CIK 0001505512

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001505512

Filing Metadata

Form type: 4
Filed: Jun 25, 8:00 PM ET
Accepted: Jun 26, 5:47 PM ET
Size: 5.5 KB

View on SEC.gov